Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Journal of General Internal Medicine
Published in: Journal of General Internal Medicine 7/2012

Open Access 01-07-2012 | Letters

Relationship Between Distal and Proximal Neoplasia

Authors: Dimitra Dodou, PhD, J. C. F. de Winter, PhD

Published in: Journal of General Internal Medicine | Issue 7/2012

Login to get access

Excerpt

Authors Reply:--- In a recent meta-analysis, we found that all types of distal lesions are predictive of proximal neoplasia (PN) and that on average 60 % of PN are isolated, that is, not accompanied by distal lesions.1 A commentary by Dr. Filik concluded that if all types of distal lesions are predictive of PN, colonoscopy should be performed instead of flexible sigmoidoscopy (FS). We thank Dr. Filik for his comment. In this reply we highlight why FS should not be abandoned in favor of colonoscopy. …
Literature
1.
Dodou D, De Winter JCF. The relationship between distal and proximal colonic neoplasia: A meta-analysis. J Gen Intern Med. 2012;27:361–370.PubMedCrossRef
2.
Levin TR, Palitz A, Grossman S, et al. Predicting advanced proximal colonic neoplasia with screening sigmoidoscopy. JAMA. 1999;281:1611–1617.PubMedCrossRef
3.
Neugut AI, Lebwohl B. Colonoscopy vs sigmoidoscopy screening. Getting it right. JAMA. 2010;304:461–462.PubMedCrossRef
4.
Imperiale TF, Wagner DR, Lin CY, Larkin GN, Rogge JD, Ransohoff DF. Using risk for advanced proximal colonic neoplasia to tailor endoscopic screening for colorectal cancer. Ann Intern Med. 2003;139:959–965.PubMed
Metadata
Title
Relationship Between Distal and Proximal Neoplasia
Authors
Dimitra Dodou, PhD
J. C. F. de Winter, PhD
Publication date
01-07-2012
Publisher
Springer-Verlag
Published in
Journal of General Internal Medicine / Issue 7/2012
Print ISSN: 0884-8734
Electronic ISSN: 1525-1497
DOI
https://doi.org/10.1007/s11606-012-2073-x

Other articles of this Issue 7/2012

Journal of General Internal Medicine 7/2012 Go to the issue

Original Research

Guideline-Based Antibiotics and Mortality in Healthcare-Associated Pneumonia

Healing Arts: Materia Medica

I’m Sorry and an Unexpected Response

Innovation and Improvement: Improvement Happens

Improvement Happens: Doctors Talk About the Medical Home

EditorialNotes

From The Editors’ Desk: Cognitive Errors, and Why We May or May Not Be as Smart as We Think We Are (or Would Like To Be)

Original Research

Disability and Decline in Physical Function Associated with Hospital Use at End of Life

Reviews

Utilization of Hepatocellular Carcinoma Surveillance Among American Patients: A Systematic Review
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine
Image Credits